Benjamin F. Edwards & Company’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-320
Closed -$4K 2142
2023
Q4
$4K Sell
320
-319
-50% -$4.43K ﹤0.01% 1891
2023
Q3
$9K Buy
+639
New +$8.99K ﹤0.01% 1412
2018
Q2
Sell
-100
Closed -$2K 1603
2018
Q1
$2K Buy
+100
New +$1.73K ﹤0.01% 1514

Other funds holding DVAX

Benjamin F. Edwards & Company's DVAX Position: Q1 2024 in Review

Benjamin F. Edwards & Company sold out of Dynavax Technologies (DVAX) in Q1 2024, closing a stake of 320 shares — an estimated $4K sold.

Benjamin F. Edwards & Company first reported a position in DVAX in Q1 2018 and held it in 3 quarters. The position peaked at $9K in Q3 2023. 244 funds tracked by Wall St. Rank hold DVAX as of Q1 2024.

  • Benjamin F. Edwards & Company reported no remaining Dynavax Technologies position as of Q1 2024 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 320 Dynavax Technologies shares in Q1 2024, an estimated $4K.
  • Benjamin F. Edwards & Company first reported a position in Dynavax Technologies in Q1 2018 and held it in 3 quarters.
  • Benjamin F. Edwards & Company's Dynavax Technologies position peaked at $9K in Q3 2023.
  • 244 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q1 2024, filed 29 Apr 2024.